Growing as a Trusted, Dedicated Commercial Biologics CDMO
Preparing the Yacht for the Race
Disaster Strikes
The Power of Aqueous Detergents in Critical Cleaning
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Designing A Recipe for Stem Cell Therapy Success
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Sailing into the Trade Winds
The Evolving Role of Remote Monitoring
Assembling the Crew
Discussing the Advancements in Oncology
Transforming Market Insights into Growth
Assessing Developability and Designing Advanceable Formulations from the Start
Rethinking the Conventional CDMO Model
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Why Life Science Companies Surged amid a Global M&A Downturn
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Plan Ahead: Mastering Your AI Budget for 2025 Success
Optimized Residual dsRNA Detection for mRNA Therapeutics
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.